{"id":"W2896809746","doi":"10.1016/j.eururo.2018.10.010","title":"Systemic Treatment of Metastatic Clear Cell Renal Cell Carcinoma in 2018: Current Paradigms, Use of Immunotherapy, and Future Directions","year":2018,"lang":"en","type":"review","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":251,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"Eisai; Pfizer Pharmaceuticals; Ipsen Biopharmaceuticals","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Cabozantinib; Immunotherapy; Oncology; Internal medicine; Kidney cancer; Bevacizumab; Systemic therapy; Systematic review; Intensive care medicine; MEDLINE; Cancer; Chemotherapy; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007318705,0.0004832793,0.001308337,0.001245458,0.000224899,0.0009272662,0.0006386909,0.0007033364,0.003109311],"category_scores_gemma":[0.0009729179,0.0001814735,0.0006968859,0.001330365,0.0003810279,0.001216038,0.0005174626,0.00135604,0.0006666121],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005265506,"about_ca_system_score_gemma":0.001359446,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009951157,"about_ca_topic_score_gemma":0.003126193,"domain_scores_codex":[0.9997919,0.00004476922,0.00003946309,0.00004041107,0.00006256882,0.00002087181],"domain_scores_gemma":[0.9995714,0.0002350334,0.000070096,0.000008999761,0.00008945737,0.00002498799],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001110976,0.00006179043,0.0003673745,0.01797633,0.0001400978,0.0001207828,0.00004429726,0.0004328728,0.0008050209,0.002820308,0.01497339,0.9621466],"study_design_scores_gemma":[0.00005784546,0.0002603479,0.001789117,0.01071842,0.000559344,0.001651427,0.0001157416,0.0003213314,0.0005894411,0.002627956,0.9812774,0.00003159605],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001324964,0.9989738,0.00008790171,0.0002755483,0.0000993631,0.000002946621,0.00001468302,0.000003571517,0.0004096454],"genre_scores_gemma":[0.001239684,0.9979101,0.0001621325,0.0003053456,0.000126594,0.000004125215,0.00002710199,0.000001205521,0.0002236655],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003109311,"threshold_uncertainty_score":0.01040167,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06739911552993089,"score_gpt":0.2986723653303573,"score_spread":0.2312732498004265,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}